Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About JPET
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About JPET
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

March 01, 1985; Volume 232,Issue 3

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 890;
  • You have access
    Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
    C J Hillard, R A Harris and A S Bloom
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 579-588;
  • You have access
    A1 and A2 adenosine receptor activation inhibits and stimulates renin secretion of rat renal cortical slices.
    P C Churchill and M C Churchill
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 589-594;
  • You have access
    Role of cyclic AMP protein kinase in decreased arterial cyclic AMP responsiveness in hypertension.
    P J Silver, R J Michalak and S M Kocmund
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 595-601;
  • You have access
    Apparent kinetics of angiotensin converting enzyme: hydrolysis of [3H]benzoyl-phenylalanyl-alanyl-proline in the isolated perfused lung.
    J H Ashton, B R Pitt and C N Gillis
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 602-607;
  • You have access
    Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
    D W Gil and B B Wolfe
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 608-616;
  • You have access
    Opioid effects on hepatic disposition of dyes in mice.
    A Hurwitz, H R Fischer, J D Innis, S Ronsse and Z Ben-Zvi
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 617-623;
  • You have access
    Metabolic activation of phosphorothioate pesticides: role of the liver.
    L G Sultatos, L D Minor and S D Murphy
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 624-628;
  • You have access
    Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    R J Gorczynski and R D Reynolds
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 629-635;
  • You have access
    Ibuprofen stereoisomer hepatic clearance and distribution in normal and fatty in situ perfused rat liver.
    J W Cox, S R Cox, G VanGiessen and M J Ruwart
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 636-643;
  • You have access
    Evaluation of polymeric hydroxamic acid iron chelators for treatment of iron overload.
    A Winston, D V Varaprasad, J J Metterville and H Rosenkrantz
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 644-649;
  • You have access
    Benzodiazepines enhance the muscimol-dependent activation of phospholipase A2 in glioma C6 cells.
    M D Majewska and D M Chuang
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 650-655;
  • You have access
    Endogenous opiate peptides may limit norepinephrine release during hemorrhage.
    J C Schadt and R R Gaddis
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 656-660;
  • You have access
    Enhanced in vivo responsiveness of presynaptic angiotensin II receptor-mediated facilitation of vascular adrenergic neurotransmission in spontaneously hypertensive rats.
    W H Cline
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 661-669;
  • You have access
    Vasoactive intestinal peptide which coexists with acetylcholine decreases acetylcholine turnover in mouse salivary glands.
    C Eva, J L Meek and E Costa
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 670-674;
  • You have access
    Pulmonary metabolism of exogenous enkephalins in isolated perfused rat lungs.
    M N Gillespie, J W Krechniak, P A Crooks, R J Altiere and J W Olson
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 675-681;
  • You have access
    Enhancement of alpha-1 and alpha-2 adrenergic agonist-induced vasoconstriction by removal of endothelium in rat aorta.
    G O Carrier and R E White
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 682-687;
  • You have access
    Effects of diacetyl monoxime on cardiac excitation-contraction coupling.
    T Li, N Sperelakis, R E Teneick and R J Solaro
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 688-695;
  • You have access
    Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    R W Fuller and S K Hemrick-Luecke
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 696-701;
  • You have access
    Synaptosomal cholesterol and phospholipid levels in several mouse strains differentially sensitive to ethanol.
    T L Smith
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 702-707;
  • You have access
    Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta.
    W Martin, G M Villani, D Jothianandan and R F Furchgott
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 708-716;
  • You have access
    Kinetics of drug action in disease states. VII. Effect of experimental renal dysfunction on the pharmacodynamics of ethanol in rats.
    M Hisaoka, M Danhof and G Levy
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 717-721;
  • You have access
    Kinetics of drug action in disease states. IX. Effect of experimental fever on phenobarbital concentrations at onset of loss of righting reflex in rats.
    M Hisaoka and G Levy
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 722-724;
  • You have access
    Modulation of reflex renal vasoconstriction by increased endogenous renal prostaglandin synthesis.
    H Holdaas, U C Kopp and G F DiBona
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 725-731;
  • You have access
    Self-cancellation of drug properties as a mode of organ selectivity: the antimuscarinic effects of ambenonium.
    T P Kenakin and D Beek
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 732-740;
  • You have access
    Effect of stimulus intensity on the profile of anticonvulsant activity of phenytoin, ethosuximide and valproate.
    S G Piredda, J H Woodhead and E A Swinyard
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 741-745;
  • You have access
    Cobalt-sensitive biphasic uptake of calcium ions in potassium-depolarized smooth muscle.
    S A Little, E Teaf and L Hurwitz
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 746-753;
  • You have access
    Cardiac cholinergic muscarinic receptors: changes in multiple affinity forms with down-regulation.
    R Roskoski, R R Reinhardt, W Enseleit, W D Johnson and P F Cook
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 754-759;
  • You have access
    Action of 5-thio-D-glucose on D-glucose metabolism: possible mechanism for diabetogenic effect.
    M J Kelley and T S Chen
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 760-763;
  • You have access
    LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphate.
    M J Schmidt, B D Sawyer, L L Truex, W S Marshall and J H Fleisch
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 764-769;
  • You have access
    Role of 5-HT2 receptors in serotonin-induced contractions of nonvascular smooth muscle.
    M L Cohen, K W Schenck, W Colbert and L Wittenauer
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 770-774;
  • You have access
    Characterization of cholecystokinin receptor sites in guinea-pig cortical membranes using [125I]Bolton Hunter-cholecystokinin octapeptide.
    C W Lin and T Miller
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 775-780;
  • You have access
    Tolerance and cross-tolerance to the antisecretory effects of enkephalins on the guinea-pig ileal mucosa.
    R Vinayek, D R Brown and R J Miller
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 781-785;
  • You have access
    Cardiorespiratory, sympathetic and biochemical responses to T-2 toxin in the guinea pig and rat.
    G Feuerstein, D S Goldstein, P W Ramwell, R L Zerbe, W E Lux, A I Faden and M A Bayorh
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 786-794;
  • You have access
    Differences in the properties of muscarinic cholinergic receptors in the developing chick myocardium.
    M M Hosey, K K McMahon, A M Danckers, C M O'Callahan, J Wong and R D Green
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 795-801;
  • You have access
    Guinea-pig model of halothane-associated hepatotoxicity in the absence of enzyme induction and hypoxia.
    C A Lunam, M J Cousins and P D Hall
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 802-809;
  • You have access
    Attenuation by atenolol of myocardial acidosis during ischemia in dogs: contribution of beta-1 adrenoceptors to myocardial acidosis.
    K Sakai and Y Abiko
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 810-816;
  • You have access
    Electrophysiologic and voltage clamp analysis of the effects of sotalol on isolated cardiac muscle and Purkinje fibers.
    E Carmeliet
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 817-825;
  • You have access
    Effects of substance P on cholinergically stimulated gastric acid secretion and mucosal blood flow in rats.
    K Yokotani and M Fujiwara
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 826-830;
  • You have access
    Behavioral effects of nonbenzodiazepine anxiolytic drugs: a comparison of CGS 9896 and zopiclone with chlordiazepoxide.
    D J Sanger, D Joly and B Zivkovic
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 831-837;
  • You have access
    CGP 22979A, a renal vasodilator with natriuretic properties.
    K G Hofbauer, C Sonnenburg, R Stalder, L Criscione, J Kraetz, W Fuhrer and E Habicht
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 838-844;
  • You have access
    Preferential renal vasodilator effects of CGP 22979A in conscious spontaneously hypertensive rats.
    J F Smits and H A Struyker-Boudier
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 845-849;
  • You have access
    Mechanism and metabolic disposition of verapamil-evoked overflow of radioactivity from isolated atria preloaded with [3H]norepinephrine.
    A Chaudhry and M M Vohra
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 850-856;
  • You have access
    Effects of N-acetylcysteine on the disposition and metabolism of acetaminophen in mice.
    G B Corcoran, E L Todd, W J Racz, H Hughes, C V Smith and J R Mitchell
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 857-863;
  • You have access
    Effects of N-acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice.
    G B Corcoran, W J Racz, C V Smith and J R Mitchell
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 864-872;
  • You have access
    Dissociation between the excitatory and "excitotoxic" effects of quinolinic acid analogs on the striatal cholinergic interneuron.
    J Lehmann, J W Ferkany, P Schaeffer and J T Coyle
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 873-882;
  • You have access
    Pharmacological analysis of alpha-2 adrenergic mechanisms in nociception and ataxia.
    D Luttinger, R Ferrari, M H Perrone and D R Haubrich
    Journal of Pharmacology and Experimental Therapeutics March 1985, 232 (3) 883-889;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 232, Issue 3
1 Mar 1985
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Read
Loading
  • NAD+ and Vitamin B3: From Metabolism to Therapies
  • Role of Tyrosine Kinase Inhibitors in Cancer Therapy
  • Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma
  • Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability
  • Canagliflozin Actions on Sodium/Glucose Cotransporters
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2018 by the American Society for Pharmacology and Experimental Therapeutics